Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Jansen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1989
The near-death experienceK L Jansen
Lancet (London, England)|January 26, 1991
Transcendental explanations and near-death experienceK L Jansen
Medical Hypotheses|January 1, 1990
Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosinsK L Jansen
BMJ (Clinical Research Ed.)|March 6, 1993
Non-medical use of ketamineK L Jansen
Clinical Neuropharmacology|December 1, 1988
The sigma receptor and movement disordersK L Jansen
Journal of Psychoactive Drugs|February 24, 2001
A review of the nonmedical use of ketamine: use, users and consequencesK L Jansen
Clinical Neuropharmacology|April 1, 1989
The sigma receptor and movement disordersK L Jansen
Drug and Alcohol Dependence|March 18, 1999
Ecstasy (MDMA) dependenceK L Jansen
The International Journal of the Addictions|February 1, 1990
Ketamine--can chronic use impair memory?K L Jansen
Trends in Neurosciences|May 1, 1988
Is treating memory impairment in Alzheimer's disease an objective?K L Jansen
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1989
The near-death experienceK L Jansen
Lancet (London, England)|January 26, 1991
Transcendental explanations and near-death experienceK L Jansen
Medical Hypotheses|January 1, 1990
Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosinsK L Jansen
BMJ (Clinical Research Ed.)|March 6, 1993
Non-medical use of ketamineK L Jansen
Clinical Neuropharmacology|December 1, 1988
The sigma receptor and movement disordersK L Jansen
Journal of Psychoactive Drugs|February 24, 2001
A review of the nonmedical use of ketamine: use, users and consequencesK L Jansen
Clinical Neuropharmacology|April 1, 1989
The sigma receptor and movement disordersK L Jansen
Drug and Alcohol Dependence|March 18, 1999
Ecstasy (MDMA) dependenceK L Jansen
The International Journal of the Addictions|February 1, 1990
Ketamine--can chronic use impair memory?K L Jansen
Trends in Neurosciences|May 1, 1988
Is treating memory impairment in Alzheimer's disease an objective?K L Jansen
Pageof 3